Myeloproliferative neoplasms (MPNs) are hematopoietic stem cell disorders encompassing chronic myeloid leukemia (BCR::ABL1 mutation positive), polycythemia vera (PV), essential thrombocythemia (ET), myelofibrosis (MF; both primary-PMF and secondary, post-PV or post-PV, MF), chronic neutrophilic leukemia, chronic eosinophilic leukemia, juvenile myelomonocytic leukemia, and MPN, not otherwise specified. This evidence concerns the gene BCR and myeloproliferative disorder.